Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-23-003525
Date:2023-01-31
Issuer: LYRA THERAPEUTICS, INC. (LYRA)
Original Submission Date:

Reporting Person:

RICHARD ROBERT E.
C/O LYRA THERAPEUTICS, INC.
480 ARSENAL WAY WATERTOWN, MA 02472

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-01-31 A 30,000 a $0.00 30,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION 2.85 2023-01-31 deemed execution date A 45,000 (a) 2033-01-30 common stock 45,000 $2.85 45,000 direct
Footnotes
IDfootnote
f1 represents an award of restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of the issuer's common stock. the rsus will vest in four (4) equal annual installments on the first four anniversaries of the grant date such that the rsus will fully vest on january 31, 2027.
f2 this option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the reporting person's service to the issuer following january 31, 2023.
WhaleWisdom Logo

Elevate your investments